Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial was to assess the dose-response relationship of symptomatic
efficacy of talsaclidine base on ADAScog and to assess safety and tolerability